The risk of stroke in patients with psoriasis

Journal of Investigative Dermatology

Volumn 129, Issue 10, 2009, Pages 2411-2418

  Gelfand, Joel M ^a   Dommasch, Erica D ^a   Shin, Daniel B ^a   Azfar, Rahat S ^a   Kurd, Shanu K ^a   Wang, Xingmei ^a   Troxel, Andrea B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTEMIC THERAPY;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 70349110553     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.112     Document Type: Article

References (38)

1. Azfar RS, Gelfand JM (2008) Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 20:416-422
2. Balci D, Balci A, Karazincir S, Ucar E, Iyigun U, Yalcin F et al. (2008) Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 23:1-6
3. Carroll K (2001) Stroke incidence and risk factors in a population-based prospective cohort study. Health Statistics Q Winter:18-26. Available at http://www.statistics.gov.uk/articles/hsq/HSQ12stroke.pdf
4. CDC (2007) Stroke.http://www.cdc.gov/stroke/risk-factors.htm, Accessed 21 February 2009.
5. Cleary P, Shorvon S, Tallis R (2004) Late-onset seizures as a predictor of subsequent stroke. Lancet 363:1184-6 Cox D (1972) Regression models and life tables. J Roy Statist Soc B 34:187-220
6. Ding S, Zhang M, Zhao Y, Chen W, Yao G, Zhang C et al. (2008) The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci 336:27-31
7. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612-1623
8. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM et al. (2008) AJC editor0 s consensus: psoriasis and coronary artery disease. Am J Cardiol 102:1631-1643
9. Gelfand JM (2007) Long-term treatment for severe psoriasis: we're halfway there, with a long way to go. Arch Dermatol 143:1191-1193
10. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ (2003) Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 139:1425-1429
11. Gelfand JM, Dattani H, Margolis DJ (2005a) The UK General Practice Research Database. Pharmacoepidemiology. B. L. Strom. New York: John Wiley and Sons 4:337-346
12. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ (2004) Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 51:704-708
13. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-1741 (Pubitemid 44547793)
14. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X et al. (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143:1493-1499
15. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005b) Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141:1537-1541
16. Gibbs RG, Newson R, Lawrenson R, Greenhalgh RM, Davies AH (2001) Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke 32:1085-1090
17. Greenland S (1996) Basic methods for sensitivity analysis of biases. Int J Epidemiol 25:1107-1116
18. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-95
19. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333-336
20. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M (2007) Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol 57:957-962
21. Huerta C, Rivero E, Rodríguez LA (2007) Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143: 1559-1565
22. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766-768
23. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodríguez LA, Ruigómez A, Meier CR et al. (2003) Validity of the general practice research database. Pharmacotherapy 23:686-689
24. Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895-902
25. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ et al. (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58:1031-1042
26. Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60:218-224
27. Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 45:649-661
28. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D et al. (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271-276
29. McColl BW, Allan SM, Rothwell NJ (2008) Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158:1049-1061
30. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA et al. (2006) Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia 49:2859-2865
31. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829-835 (Pubitemid 44556851)
32. Nightingale AL, Farmer RD (2004) Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. Stroke 35:1574-1578
33. Nijsten T, Looman CW, Stern RS (2007) Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 143:1113-1121
34. Prodanowich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:262-267
35. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J (2003) Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289:579-588
36. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG et al. (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859-865
37. Tannen RL, Weiner MG, Marcus SM (2006) Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J Clin Epidemiol 59:254-264
38. Weiner MG, Barnhart K, Xie D, Tannen RL (2007) Hormone therapy and coronary heart disease in young women. Menopause 15: 86-93